Sign In
Buy PEN
$319.37
+0.630 (+0.198%)
At Close: Jun 03, 2026
Artisan Small Cap Fund Q1 2026 Portfolio Activity
09:15am, Thursday, 07'th May 2026
During the quarter, we initiated new Garden positions in Onto Innovation, Baldwin Group and Freshpet. In addition to Compass, we added to our positions in Ollie's Bargain Outlet and Flowserve during t
Penumbra (PEN) Misses Q1 Earnings Estimates
06:25pm, Wednesday, 06'th May 2026
Penumbra (PEN) came out with quarterly earnings of $0.82 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.83 per share a year ago.
Penumbra, Inc. Reports First Quarter 2026 Financial Results
04:05pm, Wednesday, 06'th May 2026
ALAMEDA, Calif., May 6, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the first quarter ended March 31, 2026.
ALC vs. PEN: Which Stock Should Value Investors Buy Now?
12:41pm, Tuesday, 05'th May 2026
Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportuni
3 Reasons Why Penumbra (PEN) Is a Great Growth Stock
01:45pm, Monday, 27'th Apr 2026
Penumbra (PEN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Here's Why Penumbra (PEN) is a Strong Growth Stock
10:45am, Wednesday, 15'th Apr 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ALAMEDA, Calif., April 13, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) announced 90-day results of the landmark STORM-PE randomized controlled trial (RCT), which found that patients with acute in
3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
01:45pm, Friday, 10'th Apr 2026
Penumbra (PEN) could produce exceptional returns because of its solid growth attributes.
Are OMEX, PEN, SNCY, CWAN Obtaining Fair Deals for their Shareholders?
01:41pm, Friday, 10'th Apr 2026
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN
10:04pm, Tuesday, 07'th Apr 2026
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of P
Penumbra (NYSE:PEN) Director Harpreet Grewal Sells 100 Shares
04:59am, Tuesday, 07'th Apr 2026
Penumbra, Inc. (NYSE: PEN - Get Free Report) Director Harpreet Grewal sold 100 shares of the company's stock in a transaction on Thursday, April 2nd. The shares were sold at an average price of $328.2
Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?
12:31pm, Friday, 27'th Mar 2026
Penumbra (PEN) reported earnings 30 days ago. What's next for the stock?
Reasons to Retain Penumbra Stock in Your Portfolio for Now
09:51am, Friday, 27'th Mar 2026
PEN's expanding thrombectomy portfolio and global push fuel growth, but FX headwinds and macro risks may pressure near-term profitability.
Congress Asset Management Co. Trims Stake in Penumbra, Inc. $PEN
01:39pm, Tuesday, 24'th Mar 2026
Congress Asset Management Co. cut its position in shares of Penumbra, Inc. (NYSE: PEN) by 10.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchan
Penumbra, Inc. (NYSE:PEN) Given Average Rating of “Hold” by Brokerages
02:41am, Monday, 23'rd Mar 2026
Penumbra, Inc. (NYSE: PEN - Get Free Report) has received an average recommendation of "Hold" from the eighteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Fourt
